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Abstract 
BACKGROUND: Falls are associated with gait impairments in older adults (OA) and 
Parkinson’s disease (PD). Current approaches for evaluating falls risk are based on self-report 
or one-time assessment and may be suboptimal. Wearable technology allows gait to be 
measured continuously in free-living conditions. The aim of this study was to explore generic 
and specific associations in free-living gait in fallers and non-fallers with and without PD. 
METHODS: 277 fallers (155 PD, 122 older adults (OA)) who fell twice or more in the 
previous 6 months and 65 non-fallers (15 PD, 50 OA) were tested. Free-living gait was 
characterised as the volume, pattern, and variability of ambulatory bouts (Macro), and 14 
discrete gait characteristics (Micro). Macro and Micro variables were quantified from free-
living data collected using an accelerometer positioned on the low back for one week.  
RESULTS: Macro variables showed that fallers walked with shorter and less variable 
ambulatory bouts than non-fallers, independent of pathology. Micro variables within 
ambulatory bouts showed fallers walked with slower, shorter and less variable steps than non-
fallers. Significant interactions showed disease specific differences in variability with PD 
fallers demonstrating greater variability (step length) and OA fallers less variability (step 
velocity) than their non-faller counterparts (p<0.004). 
CONCLUSIONS: Common and disease specific changes in free-living Macro and Micro gait 
highlight generic and selective targets for intervention depending on type of faller (OA-PD). 
Our findings support free-living monitoring to enhance assessment. Future work is needed to 
confirm the optimal battery of measures, sensitivity to change and value for fall prediction. 
Keywords: falls, gait, Parkinson’s, wearable technology 
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Introduction 
Falls are frequent among older adults (OA) and people with Parkinson’s disease (PD); 
approximately 30% of people over 65 years of age fall each year with the fall rate increasing 
with age and for people with PD to 60% (1, 2). As the majority of falls occur while walking, 
gait impairments are commonly associated with and predict falls even in falls-naïve PD (1, 3). 
Fall related injuries cause loss of functional independence, poor quality of life and have 
associated costs to health of £1.7 billion per year in the United Kingdom alone (4), a figure 
estimated to rise due to increased longevity. Understanding falls risk and identifying key fall-
related characteristics is critical to determine effective treatment and prevention strategies (3, 
5). 
Clinical falls risk assessment is often based on questionnaires or one-time assessments of 
balance, gait and other falls risk factors. Due to their brief, subjective and sporadic nature, these 
approaches may not fully capture everyday falls risk and therefore may be suboptimal (1, 6). 
Assessments based on recall such as falls diaries may be further compromised by cognitive 
impairment, thus limiting their utility.  Falls also occur and may be precipitated by everyday 
activities and the environmental context, which is difficult to capture in a one-off assessment 
(7). It appears evident then that monitoring performance continuously during normal everyday 
activity may offer significant added benefits to understand falls risk and to enhance assessment 
of risk.  
 
In this context, wearable technology (e.g. accelerometers) is a valid and inexpensive tool to 
assess falls risk (8-12), walking activity, and gait impairment (13, 14). Continuously 
monitoring activity during unsupervised and everyday activities (free-living) may provide an 
objective and more sensitive measure of falls risk than instrumented clinical-based 
assessments, being able to discriminate between fallers and non-fallers better than the clinical 
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gait assessments (12). Free-living monitoring allows activity to be described by a broad 
framework that captures macro-structural characteristics (e.g. volume, pattern and variability 
of walking bouts) (referred to as Macro) and micro-structural characteristics that make up each 
walking bout (e.g. spatial-temporal characteristics, gait stability outcomes, gait (a) symmetry 
outcomes, gait adaptability) (referred to as Micro or quality outcomes).  Other models based 
on ‘quantity’ (e.g. volume) and ‘quality’ (e.g. endurance, variability, adaptability) measures of 
gait have also been shown to be promising in discriminating fall status in either PD or OA (10-
12, 15, 16). To date, however, it is not clear if Macro and Micro characteristics of falls risk are 
similar in older adults and PD or different. Comparing Macro and Micro gait characteristics 
with respect to falls risk and pathology may therefore be useful to highlight generic (i.e. fallers/ 
non-fallers) or disease specific (PD fallers/OA fallers) differences. This nuanced understanding 
of falls risk could stress whether to target specific intervention across groups rather than a “one-
size-fits-all” approach. Further work is therefore required to understand the nature of the 
relationship between free-living walking activity and falls risk to ultimately better inform 
strategies to reduce falls risk. 
 
The aim of this study was to describe free-living walking activity taking a broad framework 
which encapsulated both Macro and Micro features of walking and to compare differences in 
fallers and non-fallers. Secondly, we wanted to establish generic (across all participants) and 
PD-specific associations between features of walking and a history of falls. Our primary 
hypothesis was that fallers would be less active and have more impaired gait with respect to 
non-fallers; and that this these differences would be more evident in people with PD compared 
to OA. 
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Methods 
2.1 Participants 
Fallers (F) were enrolled in the V-TIME study at five clinical centres across five countries (17). 
Participants were included in the study if they had fallen twice or more in the 6 months prior 
to assessment (17). Non-fallers (NF) were recruited from the Incidence of Cognitive 
Impairment in Cohorts with Longitudinal Evaluation-GAIT (ICICLE-GAIT) study, 
participants were included if they had not fallen for at least 18 months. ICICLE-GAIT is a 
collaborative study with ICICLE-PD, an incident cohort study (Incidence of Cognitive 
Impairment in Cohorts with Longitudinal Evaluation—Parkinson’s disease) conducted 
between June 2009 and December 2011 (18). PD participants were diagnosed with idiopathic 
PD according to the UK Parkinson’s Disease Brain Bank criteria and were excluded if they 
presented with significant cognitive impairment (Mini Mental State Exam (MMSE) < 21 for 
V-TIME study and 24 for ICICLE-GAIT study (19)), psychiatric comorbidities, any 
neurological (other than PD), orthopaedic or cardiothoracic conditions that may have markedly 
affected their walking or safety during the testing sessions. 
Age and sex were recorded for each participant. The severity of PD motor symptoms was 
measured using the Hoehn and Yahr scale (20) and section III of the modified Movement 
Disorder Society version of the Unified Parkinson’s Disease Rating Scale (MDS-UPDRS (21)). 
For both studies, people with PD were assessed approximately one hour after their medication 
intake. V-TIME study testing took place at the five clinical sites (17). ICICLE-GAIT study 
testing took place at the Clinical Ageing Research Unit, Newcastle University. Both studies 
were conducted according to the declaration of Helsinki and were approved by local Ethics 
Committees (17, 18). All participants signed an informed consent form prior to testing. 
 
2.2 Free-living data collection: protocol 
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At the end of a laboratory testing session participants were asked to wear a tri-axial 
accelerometer (Axivity AX3, York, UK) on the lower back for one week as detailed in previous 
work (22). The water-proof device was programmed to capture data for seven days at 100Hz 
(range ± 8g), for more details see Supplementary methods. 
 
2.3 Data processing and analysis 
2.3.1 Data processing and variable extraction 
Once the device was received, data were downloaded and segmented (per day) and individual 
ambulatory bouts (ABs) were extracted via MATLAB® (23). Detailed data processing can be 
found in the Supplementary methods. 
Outcome measures were described according to a broad framework of Macro and Micro 
characteristics (24). Macro (behavioural outcomes) representing the volume of walking (total 
walking time per day, percentage (%) of walking time per day, number of bouts and steps per 
day), mean AB length were generated based on the AB detected over the seven days. In 
addition, a set of non-linear descriptors were also derived: (i) pattern of ABs derived using a 
power-law distribution (alpha, α) based on a logarithmic scale from their density and length 
and (ii) the within AB variability (S2) estimated using a maximum likelihood technique (22, 
25, 26). 
Micro gait characteristics (n=14 describing pace, rhythm, variability, asymmetry and postural 
control) were also determined for each walking bout. Characteristics were selected based upon 
a model of gait validated both in OA and in people with PD (27, 28). For further details on 
quantification of Micro outcomes see Supplementary Methods.  
 
2.3.2 Data considerations 
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All ABs with more than three steps (minimum bout length) were taken into account for the 
analysis (10, 14, 29, 30); a threshold of 2.5 seconds was set for the maximum resting period 
between consecutive ABs (23). Each AB was considered individually to ensure robustness for 
the evaluation of the gait characteristics, to avoid sources of error in step detection, and 
facilitate the calculation of variability and asymmetry characteristics (13). Micro outcomes 
were evaluated for each AB and then averaged over the seven days; pooled seven-day data 
were used for quantifying Macro outcomes. No further threshold was applied to ABs length 
when evaluating Macro outcomes (all ABs greater than three steps were included) (11, 12, 23), 
whilst in agreement with previous work ABs >10s were included into the analysis for the Micro 
outcomes (13, 31). 
 
2.3.3 Statistical analysis 
Statistical analysis was carried out using SPSS v19 (IBM). Normality of data and 
homoscedasticity were tested with Shapiro-Wilk test and Levene’s Test of Equality of 
Variances respectively. Descriptive statistics were reported as means and standard deviations 
(SD). Clinical characteristics were described but not used in further analysis. Effect of 
pathology and falls history were examined using general linear modelling. Fall history (F vs. 
NF) and pathology (OA vs. PD) were entered as within-person factors. Age, sex and BMI were 
included as covariates. When a pathology x fall history interaction was found, post-hoc 
secondary analysis was carried out using Tukey’s test. We used a threshold of p < 0.05 to guide 
statistical interpretation for the main effects, while a Bonferroni corrected threshold (p < 
0.0083) was used accounting for the multiple comparisons (fall status x pathology) of the post-
hoc analysis. Further analysis of Macro outcomes was then repeated on walking bouts grouped 
by bout length: medium (ABs >60s) and long (ABs>120s) ABs to explore the impact of AB 
length on results. 
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Results 
277 fallers (F: 122 Older Adult Fallers (OAF), 155 PD Fallers (PDF), age: 73.33±6.78 years), 
together with 65 non-fallers (NF: 50 Older Adult Non-Fallers (OANF), 15 PD Non-Fallers 
(PDNF), age: 69.05±7.67 years) were assessed. F were older (p<0.001) and included 
proportionally less women (F: 42%, NF: 56%). Clinical and demographic characteristics are 
shown in Table 1. 
 
Macro gait characteristics 
Mean bout length and variability were related to fall history where F walked with shorter and 
less variable walking bouts (lower S2) (Figure 1a). Volume of walking bouts (e.g. total walking 
time per day, % of walking time per day, total number of steps and bouts per day) was not 
related to fall history. 
When exploring differences based on walking bout length, a different picture emerged. ABs 
>60s represented less than 10% of the total amount of ABs, and volume of walking (based on 
total walking time per day and % of walking time per day) was significantly less in F. Longer 
ABs (>120s) represented less than 2% of the total amount of ABs, and once again volume of 
walking (based on total walking time per day, % of walking time per day and in addition 
number of bouts per day) was significantly less in F (Figure 1b and 1c).  
There were no interactions between fall history and pathology for any of the outcomes 
(Supplementary Table 2), indicating that Macro based outcomes respond in a similar manner 
irrespective of PD. 
 
Micro gait characteristics 
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Characteristics relating to pace (step velocity, step length) and variability (step length 
variability) were significantly different between F and NF. F walked with reduced velocity and 
shorter, less variable steps (Supplementary Table 3, Figure 2).  A significant interaction was 
found for fall history and PD in rhythm (step time, swing time, stance time) and variability 
(step length variability and step velocity variability) characteristics (Supplementary Table 3, 
Figure 2). PDNF had a slower step time, swing time and stance time compared to OANF (p < 
0.004, Figure 3). Although non-significant, OAF tended to walk at a slower cadence (higher 
step time, swing time and stance time) compared to OANF. In contrast PDF had a quicker time 
on all of these characteristics compared to PDNF, indicated a faster cadence overall (Figure 3). 
Variability characteristics (step length and step velocity) also showed significant interactions 
effects. Post-hoc analysis showed increased step length variability for PDF compared to PDNF 
(p = 0.004) in contrast to OAF who had reduced step velocity variability compared to OANF (p 
< 0.001), Figure 3. 
 
Discussion 
We quantified gait using a framework that captured Macro and Micro gait characteristics 
measured during free-living with a wearable accelerometer worn for one week and compared 
findings with respect to falls risk and pathology. We found an association between falls history, 
activity pattern and variability of walking bouts (Macro outcomes) regardless of pathology. In 
contrast, discrete Micro gait characteristics were not only different with respect to falls status 
but also revealed generic and PD specific associations between gait impairment and a history 
of falls. Together these findings highlight generic differences and disease specific differences 
in macro and micro characteristics that inform a nuanced understanding of falls risk and 
intervention across groups.   
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Macro characteristics 
Our findings partly support our primary hypothesis that fallers would be less active than non-
fallers, irrespective of pathology. We found that fallers were as active as non-fallers, 
irrespective of pathology, when considering the total amount of activity and our findings 
concur with others (12, 15). However, when taking bout length into account a different picture 
emerged. Fallers spent less time walking during bouts over one minute, and even less during 
bouts of two minutes. These findings are in agreement with previous studies (32, 33).  
 
Differences were also observed in the pattern and variability of all walking bouts. We found 
that fallers had a greater number of shorter walking bouts, in agreement with previous work 
reporting a higher short-walk exposure for fallers (12). Fallers also had less variability in 
walking bout duration. This may reflect restricted engagement in sustained walking bouts. 
Contrasting results have been reported for measures representing walking bout variability with 
reports of increased (16) or decreased variability (34) in fallers when compared to non-fallers. 
Comparison across studies however is difficult due to different methodological approaches and 
metrics used for describing across bout variability. Our findings that changes in Macro 
characteristics were similar for OA and PD fallers not only extend previous work, they also 
suggest that these may be fundamental features of falls risk. 
 
Agreement with previous work validates the veracity of our findings while at the same time 
raising interesting questions about the relationship between activity levels and fall 
risk/exposure (33).   Falls often occur when individuals are engaged in dynamic activities such 
as walking (5, 7, 33), and therefore it is often assumed that individuals reduce overall exposure 
to falls risk by becoming less active. The data, however, suggest that the relationship of fall 
risk and activity is more complex and influenced by duration of walking bouts, particularly 
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longer duration bouts (33). Differences observed in patterns of walking through a reduction in 
longer walking bouts may be due to compensatory change to reduce risk, possibly by reducing 
duration of walking bouts either by limiting access to the community or exercise. Alternatively, 
these changes may be related to fundamental features of falls risk. Reduction in variability of 
walking bout length in fallers may also be due to changes in patterns of walking behaviours 
indicating reduced confidence and a less varying walking “routine”. We performed further 
analysis to support this hypothesis and found that falls efficacy scale (FES-I) scores were 
negatively correlated with Macro variability (r < -0.149), showing that fallers who were less 
confident (higher FES-I score) also had a less variable walking pattern (lower variability). 
Compensatory strategies or higher attentional load (e.g. dual task) required for walking during 
free-living conditions may also play a role in modifying Macro level outcomes. At present, this 
is unclear and further work is required to understand the relationship with activity and falls 
more fully. 
 
Either way, the relationship of reduced activity, health comorbidity (such as cardiovascular 
disease and diabetes) and function is an important consideration. A reduction in sustained bouts 
of walking is problematic given the putative positive benefits of activity and the subtle, 
insidious nature of inactivity on health and disease burden. Interventions should aim to find a 
balance of maintaining activity whilst minimising falls risk, as well as the need to understand 
the relationship between these characteristics (35).  
 
Micro gait characteristics 
As hypothesised, gait impairment was more evident in fallers who walked with a slower gait 
and shorter step length compared to non-fallers. Our findings agree with previously published 
work in free-living gait (12, 16). However, of more interest were the interactions in select Micro 
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characteristics (related to rhythm and variability) indicating a different response in PDF and 
OAF compared to their non-falling counterparts. For example, variability of step velocity and 
step length showed an interesting pattern with respect to pathology and falls status with older 
adult fallers typically showing reduced variability in these characteristics and PD fallers 
increased variability compared to their non-falling counterparts. Although to date no studies 
have compared older adult and PD fallers, independent analysis of these groups in free-living 
studies lends support to our findings.  For example, previous reports have shown that PD fallers 
have increased variability (represented by width of dominant frequency) to PD non-fallers (16). 
Studies of older adult fallers have reported both higher and lower variability compared to non-
fallers depending on the outcome measure. For example, when considering the amplitude and 
slope of the dominant frequency (measures of variability of the ‘quality’ of walking), OA 
fallers were significantly more variable in the vertical axis but had less variability in the 
mediolateral axis (15). Others reported lower (although non-significant) between-walk 
variability (‘adaptability’) (12) but higher within-walk variability or mode variability (10). 
The intrinsic meaning of these differences is still unclear. Variability measured in the 
laboratory or clinic is typically greater in fallers compared to non-fallers (34) and has been 
reported to be predictive of future falls (36, 37).  For Micro level variability in free-living, the 
picture is not as clear but it seems that it is influenced by the environment or context (38). 
Possible explanations for this dichotomy could be related to the different type metrics (and 
therefore methods) used to describe variability (e.g. frequency based, within-walk variability, 
between-walk adaptability, etc.) which may indicate different constructs. Moreover while some 
studies focused on steady-state walking for evaluating variability, in the current approach we 
included also short bouts of walking. The influence of “embedded” dual-task nature of real-life 
on walking poses additional challenges and ability to adapt, and our findings raise the 
possibility of a different adaption and control strategy in OA compared to PD.  Whether they 
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reflect compensatory adaptations or primary pathological disturbances in gait underpinning 
falls is as yet unclear.  These selective differences however, suggest the need for strategies 
dependant on type of faller (OA or PD) targeting specific Micro gait characteristics (e.g. 
increase variability for PD and decrease for OA) in order to reduce falls risk.   
 
Consistent with previous results (15, 16, 39), our findings corroborate the suggestion that 
‘variability’ measures may represent different constructs. Higher variability in Macro 
outcomes (‘behaviour’) may be “good” - representing ability to engage and adapt in a wider 
variety of walking activities. Whilst higher variability in Micro outcomes may be “good” or 
“bad” representing either compensatory adaptions to minimise risk (e.g. in OA) or impaired 
control and inability to minimise risk (e.g. in people with PD). 
 
Clinical Implications 
Similar to what has been reported when investigating differences between fallers and non-
fallers both in PD and OA (10, 11, 16), we found that Micro outcomes seem to be more 
sensitive than Macro to identify selective faller x pathology “type” dependant differences (e.g. 
OAF and PDF). However, both contribute to a bigger picture that suggests group specific and 
generic features as targets for intervention development.   
 
Limitations 
This study informs understanding of the association between walking activity quantified via a 
range of Macro and Micro outcomes and falls history, however further work is required to 
identify the merits of this exploratory analysis especially in a larger sample of non-fallers. We 
acknowledge that use of different studies (V-TIME an ICICLE-GAIT) for populations of 
fallers and non-fallers and the limited number of PD fallers may affect generalisability of the 
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results. Only one model of gait including specific Macro and Micro gait characteristics was 
included in this work, in the future other reported models and outcomes should be considered 
to identify best measure (or combination of measures) for falls risk detection. In addition, 
examination of other pathologies with fall history will allow us to determine whether free-
living Macro and Micro outcomes can be a selective tool for identification of “pathology-
dependant” falls risk. Future work is also needed to examine the effect of merging short ABs, 
turning and freezing of gait on results, and to confirm if Macro and Micro outcomes can predict 
falls in order to provide an insight into falls risk for guiding clinical decision-making. 
 
Conclusions 
We found common and disease specific changes in Macro and Micro gait characteristics that 
highlight generic and selective targets for intervention in older adults and PD fallers allowing 
a more nuanced approach to falls intervention development. Macro outcomes seem to be 
associated with fall history regardless of pathology, while Micro outcomes seem to be a more 
sensitive outcome for detecting disease specific falls risk. Our findings support a role for free-
living monitoring and the use of wearable technology to enhance assessment and understanding 
of falls risk. Future work is needed to confirm the optimal battery of measures and to fully 
understand the relationship of walking in the real-world and falls risk, especially its prognostic 
utility to enhance clinical decision-making and intervention development. 
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Table 1 
Clinical and demographic characteristics for Older Adult Non-Fallers (OANF), Older Adult Fallers (OAF), participants with Parkinson’s disease 
non-fallers (PDNF) and participants with Parkinson’s disease fallers (PDF). 
Characteristic 
OANF (n=50) 
Mean (SD) 
OAF (n=122) 
Mean (SD) 
PDNF (n=15) 
Mean (SD) 
PDF (n=155) 
Mean (SD) 
p 
OANF vs OAF 
p* 
OANF vs PDNF 
p** 
OANF vs PDF 
p*** 
OAF vs PDNF 
pǂ 
OAF vs PDF 
p§ 
PDNF vs PDF 
Female (n, %) 23, 46% 95, 77.9% 4, 26.7% 59, 38.1% <.001 .183 .319 <.001 <.001 .383 
Age (years) 70.40 (6.88) 75.58 (6.32) 64.54 (8.64) 71.55 (6.44) <.001 .014 .700 <.001 <.001 .001 
BMI (kg/m2) 28.30 (4.23) 26.28 (4.29) 28.45 (4.91) 25.75 (3.69) .017 .999 .001 .204 .709 .067 
MMSE 28.40 (1.74) 28.52 (1.36) 28.87 (1.60) 28.04 (1.72) .974 .760 .554 .859 .105 .235 
Hoehn & Yahr 
(HY) stage (%) 
- - HY 2 - 100% 
HY 2 - 48.05% 
HY 2.5 - 11.69% 
HY 3 - 40.26% 
- - - - - .310 
MDS-UPDRS III - - 28.60 (5.65) 31.42 (13.17) - - - - - <.001 
Freezing of gait 
(%, Score) 
- - 
13.3%,  
7.71 (9.03) 
43.2%,  
2.13(5.64)  
- - - - - .002 
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FES-I (16-64) - 28.68 (7.68) - 35.46 (12.00) - - - - <.001 - 
ABCs (0-100%) 91.02 (11.66) - 85.64 (15.73) - - .185 - - - - 
BMI: Body Mass Index; MMSE: Mini Mental State Examination; MDS-UPDRS III: Movement Disorder Society Unified Parkinson’s Disease Rating Scale part III; FES-I: 
Falls Efficacy Scale; ABCs: Activities specific balance confidence scale. In bold significant p-values (p < 0.05). 
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Figure Captions 
Figure 1.  
Radar plot illustrating the free-living Macro gait characteristics for Fallers (F), compared to 
Non Fallers (NF), evaluated in free-living conditions for total ambulatory bouts (ABs > three 
steps, panel a), ABs > 60s (panel b), and ABs > 120s (panel c). The central dotted line 
represents NF data, deviation from zero along the axis radiating from the centre of the plot 
represents how many standard deviations the F differ from NF (range: ± 2 SD, z score based 
on NF means and standard deviations). * represents significant differences between F and NF 
(effect of Fall History) (p values < 0.05). 
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Figure 2. 
Radar plot illustrating the free-living Micro gait characteristics for Non Fallers (NF) and Fallers 
(F) evaluated in free-living conditions for ambulatory bouts > 10 seconds. The central dotted 
line represents NF data, deviation from zero along the axis radiating from the centre of the plot 
represents how many standard deviations (range: ± 2 SD, z score based on NF means and 
standard deviations) the F differ from NF. * represents significant differences between F and 
NF (effect of Fall History), ǂ represents Fall History x Pathology interactions (p values < 0.05). 
(Var: Variability, Asy: Asymmetry). 
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Figure 3. 
Post-hoc analysis results for interactions found in free-living Micro gait characteristics for 
Older Adult Fallers (OAF, in light grey), Non Fallers (OANF, in white), people with Parkinson’s 
disease Fallers (PDF, in black) and Non Faller (PDNF, in dark grey) evaluated in free-living 
conditions for ambulatory bouts > 10s. Error bars represent standard deviations. * represents 
post-hoc significant differences (p values < 0.0083). 
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Supplementary Methods 
2.2 Free-living data collection: protocol 
At the end of a laboratory testing session participants were asked to wear a tri-axial 
accelerometer (Axivity AX3, York, UK; dimensions: 23.0 × 32.5 × 7.6 mm; weight: 11 grams) 
for one week (1). The device has been validated for its suitability in capturing high-resolution 
data akin to human movement (2). It was located on the fifth lumbar vertebrae with a hydrogel 
adhesive (PAL Technologies, Glasgow, UK) and covered with additional tape (Hypafix 
bandage) for extra support. Participants were asked to continue their daily activities as usual 
and not to change their routine. Upon completion of recording, participants removed the device 
and posted it back to the researcher as detailed in previous work (3). 
 
2.3 Data processing and analysis 
2.3.1 Data processing and variable extraction 
Once the device was received, data were downloaded, segmented (per calendar day) and 
analysed using bespoke MATLAB® programs. For each day, a logical heuristics paradigm was 
embedded into walking bout identification and quantification algorithm which has shown to be 
accurate in detecting ambulatory bouts (ABs) and step count in free-living conditions (4). 
Individual ABs were extracted via MATLAB®, where a ‘bout’ was defined as the continuous 
length of time spent walking with at least three consecutive steps (3, 4). Ambulatory bouts were 
detected by applying selective thresholds on the triaxial acceleration data as detailed elsewhere 
(4).  
 
Micro outcomes 
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Micro gait characteristics (n=14) were also determined for each walking bout. Characteristics 
were selected based upon a model of gait validated both in OA and in people with PD (5, 6). 
Briefly, the initial contact and final contact events within the gait cycle were identified and 
allowed the estimation of step, stance and swing time. Initial contact events were also used to 
estimate step length using the inverted pendulum model. Step velocity was calculated as the 
ratio between step length and time (6). To calculate step variability, the standard deviation (SD) 
from all steps (left and right combined) was calculated. Asymmetry was determined as the 
absolute difference between left and right steps for each AB, averaged across all ABs (6, 7). 
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Supplementary Table 2 
Free-living Macro gait characteristics for participants grouped as Non Fallers (NF), Fallers (F), Older Adult Non-Fallers (OANF), Older Adult 
Fallers (OAF), participants with Parkinson’s disease Non-Fallers (PDNF) and participants with Parkinson’s disease fallers (PDF). Data are presented 
for total ambulatory bouts (ABs > three steps), ABs > 60s and ABs > 120s. 
Total ABs NF (n=65) F (N=277) OANF (n=50) OAF (n=122) PDNF (n=15) PDF (n=155) 
Total Walking 
Time per Day  
(Min) 
188.557 (78.459) 167.812 (68.695) 192.063 (77.529) 176.327 (66.084) 176.867 (83.144) 161.111 (70.168) 
Percentage of 
Walking  
Time 
12.730 (5.689) 11.654 (4.771) 13.172 (5.561) 12.245 (4.589) 11.257 (6.056) 11.188 (4.873) 
Number of steps 
per Day 
12691 (5497) 11853 (5045) 12995 (5629) 12408 (4992) 11677 (5082) 11416 (5060) 
Bouts per  
Day 
602 (221) 639 (219) 609 (222) 667 (206) 578 (221) 617 (226) 
Mean Bout Length  
(sec) a 
18.657 (4.188) 15.705 (4.033) 18.851 (3.855) 15.759 (3.401) 18.013 (5.253) 15.662 (4.478) 
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Variability  
(S2) a 
0.863 (0.079) 0.814 (0.082) 0.864 (0.075) 0.806 (0.071) 0.86 (0.096) 0.82 (0.09) 
Alpha (α) 1.61 (0.058) 1.642 (0.061) 1.604 (0.052) 1.636 (0.06) 1.629 (0.074) 1.646 (0.062) 
ABs > 60s       
Total Walking 
Time per Day  
(Min) a 
65.039 (39.038) 45.185 (31.17) 64.781 (36.617) 46.683 (30.419) 65.9 (47.676) 44.001 (31.801) 
Percentage of 
Walking Time a 
4.517 (2.711) 3.138 (2.165) 4.499 (2.543) 3.242 (2.112) 4.576 (3.311) 3.056 (2.208) 
Number of steps 
per Day 
5278 (3217) 4014 (2910) 5393 (3310) 4278 (2978) 4896 (2962) 3806 (2848) 
Bouts per Day 24 (13.175) 18 (12) 24 (13) 18 (10) 24 (15) 18 (13) 
Mean Bout Length 
(sec) 
163.122 (54.9) 150.015 (44.124) 164.091 (59.503) 153.19 (44.526) 159.889 (37.038) 147.503 (43.786) 
Variability (S2) 0.598 (0.127) 0.575 (0.135) 0.599 (0.137) 0.586 (0.14) 0.594 (0.086) 0.565 (0.131) 
Alpha 2.594 (0.368) 2.687 (0.502) 2.615 (0.376) 2.678 (0.545) 2.524 (0.344) 2.695 (0.467) 
ABs > 120s       
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Total Walking 
Time per Day  
(Min) a 
44.784 (30.972) 29.867 (23.667) 44.153 (29.133) 32.043 (24.326) 46.886 (37.529) 28.174 (23.079) 
Percentage of 
Walking Time a 
3.110 (2.151) 2.074 (1.644) 3.066 (2.023) 2.225 (1.689) 3.256 (2.606) 1.957 (1.603) 
Number of steps 
per Day 
3713 (2633) 2790 (2373) 3797 (2767) 3099 (2522) 3434 (2191) 2550 (2229) 
Bouts per Day a 9 (6) 7 (4) 9 (5) 7 (4) 10 (6) 6 (5) 
Mean Bout Length 
(sec) 
292.540 (135.232) 265.275 (86.672) 297.584 (147.531) 273.06 (81.349) 275.728 (83.836) 259.221 (90.397) 
Variability (S2) 0.522 (0.164) 0.463 (0.15) 0.53 (0.179) 0.49 (0.155) 0.495 (0.096) 0.442 (0.142) 
Alpha 2.918 (0.772) 2.997 (1.405) 2.946 (0.855) 2.978 (1.877) 2.824 (0.398) 3.011 (0.887) 
Significant (p < 0.05) effect of Fall History (a, difference between NF and F) are shown for each variable. No effect of Fall History x Pathology was found 
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Supplementary Table 3 
Free-living Micro gait characteristics for participants grouped as Non Fallers (NF), Fallers (F), Older Adult Non-Fallers (OANF), Older Adult 
Fallers (OAF), participants with Parkinson’s disease Non-Fallers (PDNF) and participants with Parkinson’s disease fallers (PDF). Data are presented 
for ABs > 10s. 
ABs > 10s NF (n=65) F (N=277) OANF (n=50) OAF (n=122) PDNF (n=15) PDF (n=155) 
Pace       
Step Velocity (m/s) a 1.11 (0.112) 1.019 (0.110) 1.127 (0.105) 1.050 (0.113) 1.055 (0.120) 0.994 (0.100) 
Step Length  (m) a 0.612 (0.04) 0.567 (0.049) 0.615 (0.038) 0.587 (0.048) 0.603 (0.046) 0.551 (0.045) 
Swing Time Var (s) 0.143 (0.023) 0.146 (0.018) 0.142 (0.019) 0.139 (0.015) 0.147 (0.032) 0.152 (0.017) 
Variability       
Step Velocity Var (m/s) b 0.372 (0.066) 0.351 (0.049) 0.382 (0.067) 0.342 (0.048) 0.340 (0.049) 0.358 (0.049) 
Step Length Var (m) a,b 0.146 (0.017) 0.145 (0.014) 0.147 (0.016) 0.142 (0.015) 0.139 (0.020) 0.148 (0.013) 
Step Time Var  (s) 0.172 (0.028) 0.174 (0.023) 0.171 (0.023) 0.164 (0.020) 0.177 (0.043) 0.181 (0.023) 
Stance Time Var (s) 0.185 (0.031) 0.186 (0.026) 0.184 (0.025) 0.175 (0.022) 0.190 (0.046) 0.194 (0.026) 
Rhythm       
Step Time (s) b 0.596 (0.037) 0.597 (0.031) 0.589 (0.028) 0.597 (0.03) 0.618 (0.055) 0.597 (0.031) 
Swing Time (s) b 0.448 (0.030) 0.454 (0.029) 0.443 (0.024) 0.455 (0.03) 0.466 (0.043) 0.453 (0.029) 
Stance Time (s) b 0.745 (0.042) 0.743 (0.034) 0.738 (0.033) 0.742 (0.033) 0.769 (0.060) 0.744 (0.035) 
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Asymmetry  
      
Step Time Asy (s) 0.071 (0.019) 0.071 (0.016) 0.069 (0.014) 0.067 (0.016) 0.079 (0.029) 0.073 (0.016) 
Swing Time Asy (s) 0.064 (0.019) 0.064 (0.014) 0.061 (0.012) 0.061 (0.013) 0.074 (0.033) 0.066 (0.013) 
Stance Time Asy (s) 0.072 (0.021) 0.071 (0.016) 0.069 (0.014) 0.067 (0.015) 0.082 (0.033) 0.073 (0.017) 
Postural Control 
      
Step Length Asy (m) 0.075 (0.010) 0.069 (0.014) 0.075 (0.010) 0.073 (0.015) 0.075 (0.012) 0.066 (0.012) 
Var: Variability; Asy: Asymmetry. Significant (p < 0.05) effect of Fall History (a, difference between NF and F) are shown for each variable and effect of Fall History x 
Pathology (b). 
 
 
